Ozempic under suspicion: FDA warned of the risk of sudden vision loss from popular weight-loss drugs
The U.S. Food and Drug Administration (FDA) has announced a potentially dangerous side effect of popular drugs for treating diabetes and weight loss. This concerns Ozempic, Wegovy, and other GLP-1-based medications, which may be linked to a rare optic nerve disease.